Drug intelligence / Profile preview

Xiaoer Qingzhen Oral Liquid

Development stage
Unknown
Lead developer
Shandong Kangzhonghong
Modality
Small Molecules
Administration
Oral
01

Overview

Xiaoer Qingzhen Oral Liquid is an investigational Traditional Chinese Medicine (TCM) developed by Shandong Kangzhonghong Pharmaceutical Technology Development Co., Ltd. specifically for the treatment of hand, foot, and mouth disease (HFMD) in pediatric patients. The formulation is designed to clear heat, detoxify, and cool the blood, addressing the clinical manifestations of HFMD such as fever, skin rashes, and oral ulcers. It is administered as an oral solution and is composed of several herbal extracts known for their antiviral and anti-inflammatory properties. Clinical evaluation in China, including Phase II trials, has focused on its efficacy in reducing the duration of symptoms and preventing the progression of the disease caused by enteroviruses such as Enterovirus 71 (EV71) and Coxsackievirus A16 (CV-A16).

Brand names
Xiao'er Qingzhen Oral Liquid
Other names
小儿清珍口服液Xiao'er Qingzhen Koufuye
02

Targets

CA16 (Coxsackievirus A16)

Beyond the preview

Go deeper on Xiaoer Qingzhen Oral Liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaoer Qingzhen Oral Liquid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call